These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19145612)

  • 1. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors.
    Abell AD; Jones MA; Coxon JM; Morton JD; Aitken SG; McNabb SB; Lee HY; Mehrtens JM; Alexander NA; Stuart BG; Neffe AT; Bickerstaffe R
    Angew Chem Int Ed Engl; 2009; 48(8):1455-8. PubMed ID: 19145612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.
    Stuart BG; Coxon JM; Morton JD; Abell AD; McDonald DQ; Aitken SG; Jones MA; Bickerstaffe R
    J Med Chem; 2011 Nov; 54(21):7503-22. PubMed ID: 21955158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
    Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
    Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A macrocyclic calpain inhibitor slows the development of inherited cortical cataracts in a sheep model.
    Morton JD; Lee HY; McDermott JD; Robertson LJ; Bickerstaffe R; Jones MA; Coxon JM; Abell AD
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):389-95. PubMed ID: 23211821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpains: enzymes of vision?
    Biswas S; Harris F; Dennison S; Singh JP; Phoenix D
    Med Sci Monit; 2005 Sep; 11(9):RA301-10. PubMed ID: 16127377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpains: targets of cataract prevention?
    Biswas S; Harris F; Dennison S; Singh J; Phoenix DA
    Trends Mol Med; 2004 Feb; 10(2):78-84. PubMed ID: 15102361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling studies of peptide inhibitors highlight the importance of conformational prearrangement for inhibition of calpain.
    Jiao W; McDonald DQ; Coxon JM; Parker EJ
    Biochemistry; 2010 Jul; 49(26):5533-9. PubMed ID: 20499928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain may contribute to hereditary cataract formation in sheep.
    Robertson LJ; Morton JD; Yamaguchi M; Bickerstaffe R; Shearer TR; Azuma M
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4634-40. PubMed ID: 16303960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of calpains in opacification induced by Ca2+-overload in ovine lens culture.
    Lee HY; Morton JD; Sanderson J; Bickerstaffe R; Robertson LJ
    Vet Ophthalmol; 2008; 11(6):347-55. PubMed ID: 19046274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
    Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
    Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Virtual Screening and Biological Evaluation of a Calpain Inhibitor for Prevention of Selenite-Induced Cataractogenesis in an in Vitro System.
    Muralidharan AR; Selvaraj C; Singh SK; Sheu JR; Thomas PA; Geraldine P
    J Chem Inf Model; 2015 Aug; 55(8):1686-97. PubMed ID: 26270943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenite nuclear cataract: review of the model.
    Shearer TR; Ma H; Fukiage C; Azuma M
    Mol Vis; 1997 Jul; 3():8. PubMed ID: 9238097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into the P3 binding domain of m-calpain using photoswitchable diazo- and triazene-dipeptide aldehydes: new anticataract agents.
    Abell AD; Jones MA; Neffe AT; Aitken SG; Cain TP; Payne RJ; McNabb SB; Coxon JM; Stuart BG; Pearson D; Lee HY; Morton JD
    J Med Chem; 2007 Jun; 50(12):2916-20. PubMed ID: 17497840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
    Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel series of urea-based peptidomimetic calpain inhibitors.
    Sanders ML; Donkor IO
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors.
    Jones MA; Morton JD; Coxon JM; McNabb SB; Lee HY; Aitken SG; Mehrtens JM; Robertson LJ; Neffe AT; Miyamoto S; Bickerstaffe R; Gately K; Wood JM; Abell AD
    Bioorg Med Chem; 2008 Jul; 16(14):6911-23. PubMed ID: 18571418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
    Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
    Zeng Y; Li Q; Hanzlik RP; Aubé J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human mu-calpain by conformationally constrained calpastatin peptides.
    Pfizer J; Assfalg-Machleidt I; Machleidt W; Schaschke N
    Biol Chem; 2008 Jan; 389(1):83-90. PubMed ID: 18095873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.